title: Application of a two-phenotype color-shift model with heterogeneous growth to a rat hepatocarcinogenesis experiment.
abstract: The color-shift model (CSM) was introduced by Kopp-Schneider et al. [1] to describe formation and progression of foci of altered hepatocytes (FAH). It incorporates the field-effect hypothesis which postulates that entire colonies of altered hepatocytes simultaneously alter their phenotype. In the original CSM, FAH grow with deterministic growth rate and change their phenotype after an exponentially distributed waiting time. A modification of the original color-shift model (CSM beta) is presented here in which the growth rate varies from focus to focus according to a beta distribution. The concept of an exponentially distributed waiting time to phenotype change is modified to the concept of a random radius at which phenotype changes and this radius is modelled as beta distributed. The original and the modified CSM are applied to data from an initiation-promotion rat hepatocarcinogenesis experiment with diethylnitrosomorpholine (DEN) and N-nitrosomorpholine (NNM), in which two phenotypes of FAH were observed in hematoxilin/eosin (H&E) stained liver sections. The Cramer-von-Mises Distance is used as a measure for the discrepancy between empirical and theoretical size distributions. Comparisons of model fit show that considerable improvement is obtained for CSM beta compared to the original CSM.
authors.affiliation: Department Biostatistics-C060, German Cancer Research Center, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany.
authors.forename: Jutta
authors.initials: J
authors.lastname: Groos
authors.forename: Annette
authors.initials: A
authors.lastname: Kopp-Schneider
mesh_terms: D000465:Algorithms; D000818:Animals; D002273:Carcinogens / Q000494:pharmacology; D049109:Cell Proliferation / Q000187:drug effects; D003116:Color; D022781:Hepatocytes / Q000187:drug effects / Q000473:pathology*; D016013:Likelihood Functions; D008099:Liver / Q000187:drug effects / Q000473:pathology; D008114:Liver Neoplasms, Experimental / Q000139:chemically induced / Q000473:pathology*; D008297:Male; D008954:Models, Biological; D009602:Nitrosamines / Q000494:pharmacology; D010641:Phenotype; D051381:Rats; D013194:Staining and Labeling
chemical_list: D002273:Carcinogens; D009602:Nitrosamines; C002741:N-nitrosomorpholine